https://www.cellprothera.com/en/technology-networks-could-regenerative-medicine-reverse-damage-after-a-heart-attack/2026-07-02T10:34:09+02:00 https://www.cellprothera.com/time-france-health-palmares-2026-des-20-personnalites-qui-font-la-sante/2026-06-30T10:52:00+02:00 https://www.cellprothera.com/en/cellprothera-prepares-for-phase-3-push-as-regenerative-cardiology-moves-closer-to-clinical-reality/2026-06-02T11:44:57+02:00 https://www.cellprothera.com/le-mensuel-grand-est-les-champions-de-la-sante/2026-06-02T11:15:09+02:00 https://www.cellprothera.com/en/cellprothera-appoints-jerome-hirtzlin-and-anne-de-la-fortelle-to-board-of-directors-for-late-stage-clinical-development/2026-05-06T11:14:38+02:00 https://www.cellprothera.com/en/transendocardial-cell-delivery-in-post-acute-myocardial-infarction/2026-05-05T10:27:53+02:00 https://www.cellprothera.com/cellprothera-sassocie-a-quintessence-biotech-pour-industrialiser-les-procedes-de-fabrication-cellulaire-en-vue-des-essais-cliniques-dans-lavc/2026-04-29T09:02:18+02:00 https://www.cellprothera.com/en/cellprothera-collaborates-with-quintessence-biotech-to-industrialize-cell-manufacturing-processes-ahead-of-stroke-clinical-trials/2026-04-28T16:08:57+02:00 https://www.cellprothera.com/en/why-a-cell-therapy-ceo-waited-until-phase-iii-to-outsource/2026-04-16T14:52:22+02:00 https://www.cellprothera.com/en/getting-advanced-therapies-into-patients-targeted-cell-delivery/2026-04-15T11:12:58+02:00 https://www.cellprothera.com/en/cellprothera-sets-the-scene-for-phase-iii-stem-cell-therapy-trial/2026-03-19T09:12:30+01:00 https://www.cellprothera.com/en/cellprothera-acquires-full-rights-to-transendocardial-catheter-developed-by-celyad-oncology/2026-02-12T10:16:28+01:00 https://www.cellprothera.com/cellprothera-acquiert-les-droits-complets-du-catheter-transendocardique-developpe-par-celyad-oncology/2026-02-12T10:16:38+01:00